We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...

Global health company The Cigna Group (NYSE: CI) will release its first quarter 2025 financial results on Friday, May 2, 2025, and will host a conference call the same day. The FTC chair had ...

Truist raised the firm’s price target on Cigna (CI) to $385 from $375 and keeps a Buy rating on the shares as part of a broader research note ...

Fintel reports that on April 9, 2025, Guggenheim initiated coverage of Cigna Group (NYSE:CI) with a Buy recommendation.

The Cigna Group stands poised to reap the rewards of utilization normalization in the back-half of the decade. Specifically, the company is taking steps to reduce exposure to government programs such ...

Jefferson Health took the bold step of going out of network with Cigna with the aim of strengthening its position with the ...

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of the key U.S. life/health subsidiaries ...

StockNews.com upgraded shares of The Cigna Group (NYSE:CI – Free Report) from a buy rating to a strong-buy rating in a research note released on Saturday morning. CI has been the topic of several ...

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.

Optum, Express Scripts seek to oust judge in opioid cases Pharmacy benefit managers OptumRx and Express Scripts have asked the federal judge overseeing nationwide litigation over the opioid crisis ...